Journal of Cytokine Biology
Open Access

Cytokine profile; Immunofluorescent; Acute lymphoblastic leukaemia; Fluorochromes

Introduction

The efficiency of an ongoing immune response depends on the cytokines produced by T helper types 1 (Th1) and 2 (Th2), as well as T cytotoxic types 1 (Tc1) and 2 (Tc2). Patients with cancer may experience reduced T-cell-mediated immune system activity due to dysregulated growth of one or both subsets. In the current investigation, we looked into the possibility of such dysregulation in young patients with acute lymphoblastic leukaemia (ALL) [1]. C D4 Th cells can be divided into various categories that each release distinctive clusters of cytokines, some of which regulate cell-mediated immune responses and others of which promote B cell synthesis of antibodies. Th2 cells produce additional cytokines, such as IL-4, IL-5, IL-10, and IL-13, which guide allergic or anti-inflammatory responses as well as support some B cell responses. Thl cells produce IL-2, IFN-’, and lymphotoxin, which enhance delayed-type hypersensitivity responses. In murine and human systems, Th cells that produce cytokines typical of both Thl and Th2 clones have also been reported. These cells are known as Th0 cells, and they may be the polarised Thl and Th2 phenotypes’ ancestors [2]. In other circumstances, however, Th0 cells might indeed be a distinct, stable population. Interest in cytokines as treatments is growing. To explore the intrinsic biological features of natural ligands, therapeutic cytokine discovery is typically restricted to tissue targeting, affinity maturation, and/or half-life extension. More recently, cytokine engineering efforts have shown that protein design and selective structure-based engineering can reduce cytokine pleiotropy [3]. However, unlike multi-pass transmembrane proteins that respond to small molecule agonists, such as GPCRs and ion channels, cytokines are proteins that signal through type-I single-pass transmembrane receptors, which pose significant difficulties for the discovery of small molecule agonists. The mLN is where early SFB-induced Th17 cell differentiation takes place. Early RORt expression by SFB-specific Th17 cells requires IL-6. IL-6, IL-21, and IL-23 play various roles in the generation of Th17 effector cytokines, and IL-21 or IL-23 induce delayed differentiation of Th17 cells in the absence of IL-6 [4].

Material and Method

T cells are activated to produce responses by being exposed to liquid stimulants in tubes, plates, or lyophilized stimulants in plates. To improve cytokine responses, the costimulatory antibodies CD28 and CD49d are occasionally introduced [5]. During stimulation, a Golgi-blocking drug (such as monensin or brefeldin A) is also added to maintain the produced cytokine inside the cell. Depending on the markers to be assessed, a different blocking agent and stimulation time will be used. If possible, a control sample that was not stimulated but was subjected to the same circumstances is supplied for comparison [6].

Fluorophores and antibodies

It might be difficult to decide which antibodies to use with which fluorochromes, especially when using multiparameter flow cytometry. The quantity and type of lasers in the apparatus will undoubtedly restrict the range of fluorochromes that can be used. The brightest fluorochromes among them must typically be saved for the faintest markers, when the greatest resolution sensitivity is needed. This enables the use of brightly staining agents like CD3, CD4, or CD8 with weaker fluorochromes [5,6]. Avoiding spillover from bright populations into detectors that would be most negatively impacted by overlap problems, such as those with dim markers or with extremely uncommon occurrences, is especially crucial when creating an antibody cocktail. For instance, one should avoid combining a strongly staining AmCyan conjugate with a poorly stained FITC conjugate that stains the same cell population due to the spectrum overlap of AmCyan into the FITC channel [7].

Processing of samples

Cell therapy development, manufacture, and application continue to face substantial challenges with regard to in-process monitoring and control of biomanufacturing workflows [8,9]. To guarantee consistent and predictable safety, efficacy, and potency of clinical products, new process analytical methods must be developed to identify and manage the crucial process parameters that influence ex vivo cell growth and differentiation. There are various categories of functional indicators that have similar ideal stimulation conditions [10]. For instance, the majority of cytokines, including as IL-2, IL-4, IL-5, IL-13, IFN, MIP- 1, and TNF, peak between 6 and 12 hours after stimulation. Although CD154 keeps this level of expression for up to 24 hours (26), CD107 and CD154 reach their peak expression only after 6 hours of stimulation, therefore both of these antibodies should be incubated with the cells throughout the stimulation time period. The best time to stimulate IL- 10 and TGF is between 12 and 24 hours, and serum-free media is better for detecting TGF [11-13].

Result and Discussion

We first investigated the pattern of cytokine staining in established Thl and Th2 clones, known only to produce each cytokine by reverse transcription PCR, in order to validate the method of cytokine analysis by flow cytometry. IFN-/ and IFN-/ are mutually exclusive and exhibit different kinetics during intracellular synthesis in established Th l and Th2 clones. This study’s objective was to simultaneously analyse intracellular synthesis of IFN-/ or IL-4 by maturing T cells derived from naive TCR-etl3 transgenic CD4+ T cells challenged with particular antigen in the presence of IL-4 or IL-12 using flow cytometry. It is unclear, in example, whether cells within a Thl or Th2 population primarily generate IFN- and IL-4 or whether they are able to create both cytokines at the same time. We also address this in Th0 clones that have been shown using immunoassay to produce both cytokines. The platform allows for quick, label-free metabolic measurements from a small number of cells, allowing for the early detection of spectral markers and metabolic pathways associated with T-cell activation and differentiation. As opposed to traditional techniques of T-cell evaluation, this is accomplished while using less analytical time and resources.

Conclusion

This work highlights the potential of in-process monitoring and dynamic feedback control strategies via metabolic modulation to drive T-cell activation, proliferation, and differentiation throughout biomanufacturing, in addition to opportunities for fundamental insights into the dynamics of T-cell processes. Brefeldin A has the largest impact on IL-2, IL-4, IL-5, IL-13, IFN, and MIP-1. With monensin, CD107, CD154, IL-10, and TGF all perform better. Finally, monensin has no impact whatsoever on TNF secretion.

Acknowledgement

None

1. Pi CH, Hornberger K, Dosa P, Hubel A (2020) Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants. Cytotherapy 22:291-300.

Indexed at, Google Scholar, Crossref

2. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al.( 2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106–111.

Indexed at, Google Scholar, Crossref

3. Ellefsen K, Harari A, Champagne P, Bart PA, Sekaly RP, et al.( 2002) Distribution andfunctional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomeg-alovirus infections. Eur J Immunol 32:3756–3764.

Indexed at, Google Scholar, Crossref

4. Liu H, Rhodes M, Wiest DL, Vignali DA (2000) On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 13:665-675.

Indexed at, Google Scholar, Crossref

5. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionallydistinct populations of virus-specific CD4 T cells in HIV-1-infected subjects withprogressive disease: Changes after antiretroviral therapy. Blood 103:966–972.

Indexed at, Google Scholar, Crossref

6. Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, et al. (2002) Cytomegalovirus(CMV) phosphoprotein 65 makes a large contribution to shaping the T cell reper-toire in CMV-exposed individuals. J Infect Dis 185:1709–1716.

Indexed at, Google Scholar, Crossref

7. Kern F, Faulhaber N, Frommel C, Khatamzas E, Prosch S, et al. (2000) Analysis of CD8 T cell reactivity to cy-tomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur JImmunol 30:1676–1682.

Indexed at, Google Scholar, Crossref

8. Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, et al. (2001) Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J ImmunolMethods 255:27–40.

Indexed at, Google Scholar, Crossref

9. Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, et al. (2003) HIV-1 viremia prevents the establishment of interleukin 2-producingHIV-specific memory CD41T cells endowed with proliferative capacity. J Exp Med 198:1909–1922.

Indexed at, Google Scholar, Crossref

10. Chen W, Li L, Brod T, Saeed O, Thabet S, et al. (2011) Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. Journal of Biological Chemistry 286:13846-13851.

Indexed at, Google Scholar, Crossref

11. Patel CH, Powell JD (2017) Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease. Current Opinion in Immunology 46:82-88.

Indexed at, Google Scholar, Crossref

12. Horton H, Thomas EP, Stucky JA, Frank I, Moodie Z, et al. (2007) Optimization and validation of an 8-color intracellular cytokinestaining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J Immunol Methods 323:39–54.

Indexed at, Google Scholar, Crossref

13. Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, et al. (2005) Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELI-SPOT. BMC Immunol 6:17.

Indexed at, Google Scholar, Crossref